FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
27,704,329
Share change
-3,360,121
Total reported value
$167,060,252
Price per share
$6.03
Number of holders
109
Value change
-$26,174,499
Number of buys
61
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q2 2019

As of 30 Jun 2019, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,704,329 shares. The largest 10 holders included BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., FMR LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Man Group plc, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.